In addition, ELOVL4 is upregulated in GC, and higher ELOVL4 expression predicts a poorer prognosis; inhibition of ELOVL4 suppresses GC tumorigenesis in vivo. This evidence concerns the gene ELOVL4 and gastric cancer.